Generex Awarded Two New Patents for Its Proprietary Buccal Drug Delivery System
01 juin 2010 09h30 HE
|
Generex Biotechnology Corp.
WORCESTER, Mass., June 1, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the...
Generex Biotechnology to Participate in American Society of Clinical Oncology Annual Meeting in Chicago
26 mai 2010 09h30 HE
|
Generex Biotechnology Corp.
WORCESTER, Mass., May 26, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com) today announced that its wholly owned subsidiary, Antigen Express, Inc....
Generex Biotechnology Announces Publication of Novel Immunotherapeutic Cancer Vaccine Results in Patients With Prostate Cancer
18 mai 2010 10h04 HE
|
Generex Biotechnology Corp.
WORCESTER, Mass., May 18, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) announced today publication of results from the first Phase I study of its lead immunotherapeutic...
Generex Biotechnology Hosts Satellite Symposium at CODHy 2010
13 mai 2010 09h30 HE
|
Generex Biotechnology Corp.
WORCESTER, Mass., May 13, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the...
Generex Biotechnology Achieves Enrollment of Over 400 Subjects in Phase III Generex Oral-lyn(TM) Study
10 mai 2010 09h10 HE
|
Generex Biotechnology Corp.
WORCESTER, Mass., May 10, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the...
Generex Receives NASDAQ Non-Compliance Notice
07 mai 2010 17h18 HE
|
Generex Biotechnology Corp.
WORCESTER, Mass., May 7, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com) today announced that on May 6, 2010 the Company was notified by the NASDAQ staff...
Generex Receives New US Patent for Its Proprietary Buccal Drug Delivery Platform Technologies
29 avr. 2010 09h30 HE
|
Generex Biotechnology Corp.
WORCESTER, Mass., April 29, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of...
Generex Announces Updated Phase I Results From Novel Immunotherapeutic Vaccine Presented at the European Association of Urology Congress
27 avr. 2010 09h30 HE
|
Generex Biotechnology Corp.
WORCESTER, Mass., April 27, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com) today announced presentation of additional results from a recently completed...
Generex Establishes Action Plan for Reimbursement Coverage for Generex Oral-lyn(TM)
19 avr. 2010 09h30 HE
|
Generex Biotechnology Corp.
WORCESTER, Mass., April 19, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of...
Generex Announces New Treatment IND Site for the USFDA Expanded Access Treatment IND Program for Generex Oral-lyn(tm) in the United States
13 avr. 2010 09h30 HE
|
Generex Biotechnology Corp.
WORCESTER, Mass., April 13, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of...